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Aim of the study: Conservative management of gastrooesophageal reflux (GORD) in oesophageal atresia (OA) is
sometimes inefficient, and fundoplication is required.We assessed the outcomes of fundoplication amongOApa-
tients from 1980 to 2016.
Methods: After ethical consent, hospital records of 290 patients, including 22 referred patients, were reviewed.
Includedwere 262 patientswith end–to–end repair. Excludedwere patientswhounderwent oesophageal recon-
struction (n = 23) or no repair (n = 5). Primary outcome measures included survival, retaining the native oe-
sophagus, resolution of GGORD symptoms, failure of fundoplication, and long-term endoscopic results.
Main results:Gross types of OA in 262 patients were A (n= 12), B (n= 2), C (n= 217), D (n= 10), E (n= 19),
and F (n=2). Eighty-six (33%) patients, type A (n=12, 100%), B (n= 2, 100%), C (n=69, 31%), D (n=3, 30%),
and F (n = 1, 50%), underwent fundoplication at the median age of 5.4 (IQR 3.1–16) months. Main indications
included recalcitrant anastomotic stenosis (RAS) in 41 (48%), respiratory symptoms in 16 (19%), and acute life
threatening events (ALTE) in 15 (17%) of patients. Associated tracheomalacia in 25 (29%) patients were treated
with aortopexy. Median follow–up was 7.5 (IQR 1.8–15) years. RAS resolved in 30 (73%) patients, whereas 11
(27%) with unresolved RAS underwent oesophageal resection (n= 8) or replacement (n= 3). Six (7%) patients
died of heart failure (n = 4), bolus impaction (n = 1), and ALTE (n = 1). Fundoplication failed in 27 (31%) pa-
tients, and 13 (15%) underwent redo fundoplication. Fundoplication failure was predicted by long-gap OA RR=
3.8 (95%CI = 1.1–13), P = 0.04. In total GORD associated symptoms persisted in 7 (8%) patients, including one
with permanent feeding jejunostomy. Latest endoscopy showed moderate or severe oesophagitis in 7% of
fundoplicated and in 3% nonfundoplicated patients and intestinal metaplasia in 3% and 1% (p = 0.20–0.29).
Conclusion: Fundoplication provided a safe and relatively effective control of OA associated symptomatic GORD
and oesophagitis. The failure rate of fundoplication was high in those with long-gap OA.
Type of study: Treatment study.
Level of evidence: IV
© 2017 Elsevier Inc. All rights reserved.After repair of oesophageal atresia (OA) gastrooesophageal reflux dis-
ease (GORD) is a common postoperative problem. The anatomy and the
innervation of the repaired oesophagus differ considerably from a normal
oesophagus. Functional impairment of the repaired oesophagus with no
effective peristaltics and poor clearance of liquid and solid contents and
without co-operation between the body of the oesophagus and the
lower oesophageal sphincter (LES) muscle predispose to GORD. The
symptomsofOA associatedGORD include vomiting, dyspnoea, aspiration,
wheezing, dysphagia and apneic spells. GORDmay also predispose to re-
current anastomotic stenosis. Although the symptoms of OA associated
GORD are not unlike GORD symptoms in otherwise healthy infants, an in-
fant with OA associated GORD is frequently exposed to life-threatening
events that require rapid response from the clinician. In such situationsection of Paediatric Surgery,
land. Tel.: +358 504272512;
.
conservative management by positioning, antireflux medication or
waiting of the disappearance of the symptoms by infants growth may
be not be safe and effective, and antireflux surgery ie, fundoplication is
the treatment of choice [1,2]. Although the incidence of fundoplication
varies widely from 9% to 40% depending on the type of OA and treating
centre [3–5] fundoplication is themost commonmajor surgical procedure
in patients with OA.
In this retrospective observational studywe present the outcomes of
fundoplication among 290 successive patients with OA from 1980 to
2016. Main outcome measures were survival, resolution of symptoms,
preservation of native oesophagus, failure of fundoplication and long-
term endoscopic results.
1. Materials and methods
Consent from the ethical board was obtained. Patients assessed in
the present study have been assessed by the same authors in previous
Table 1
Fundoplications in 262 patients with native oesophagus and primary anastomosis. Rate of
fundoplication by type of oesophageal atresia (OA) and by associated diseases.
Total (n = 262) Fundoplication
(n = 86) (32%)
No Fundoplication
(n = 176) (68%)
Type of OA (primary anastomosis)
A (n = 12) 12 (100%) 0
B (n = 2) 2 (100%) 0
C (n = 217) 69 (32%) 147 (68%)
D (n = 10) 3 (33%) 7 (67%)
E (n = 17) 0 (0%) 17 (100%)
F (n = 2) 1 (50%) 1 (50%)
Associated disease (patients) P
Congenital Heart Disease (n = 74) 24 (28%) 50 (28%) 0.99
Duodenal Atresia (n = 23) 9 (10%) 14 (9%) 0.49
Anorectal Malformation (n = 34) 13 (15%) 21 (12%) 0.56
Prematurity (n = 99) 40 (40%) 59 (32%) 0.06
Tracheomalacia/aortopexy (n = 32) 25 (29%) 7 (4%) b0.001
Airway malformation (n = 40) 15 (17%) 20 (11%) 0.18
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in patients with OA. Patients were identified with the help of manual
operation theatre diary from 1980 to 1997 and from computerized ar-
chives with the help of ICD codes from 1990 to 2016. All patient data in-
cluding surgical reports of the primary repair and fundoplication,
endoscopic follow-up data and data of symptoms, radiologic imaging
or other tests relevant for diagnosis of GORD were collected by review
of the hospital records. Themain indication for fundoplication was clin-
ically acute GORD that was unmanageable with proton pump inhibitors
(omeprazole or lanzoprazole 1–2 mg/kg once daily), positioning or
feeding adjustments. In order to assess the oesophageal anastomosis
and oesophagitis all patients with pending fundoplication underwent
at least one oesophagogastroscopy combined with balloon dilatation
(Pentax balloon dilatator w/wo wire guide) of anastomotic stenosis if
necessary. Indication for endoscopic dilatation was dysphagia; contrast
radiographs were not used routinely as the basis of performing a bal-
loon dilatation. In case of recurring or recalcitrant anastomotic stenosis
aminimumof six endoscopic balloon dilatationswere performed before
fundoplicationwas considered. Dilatations were performed by gradual-
ly increasingmaximum balloon diameter from 6mm in the first session
(threeweeks after the primary repair) to 10–11mm in the later sessions
with aminimumof oneweek interval between sessions. Oesophageal pH/
impedance monitoring and upper gastrointestinal tract contrast series
were used whenever clinically practicable. Endoscopies of the upper gas-
trointestinal tract were performed with small or baby-sized flexible
videogastroscope (Pentax EG 2985, Japan) and endoscopies of airway
with flexible videobronchoscope (Pentax, Japan) or with (2.5–4.5 mm)
rigid bronchoscope (Karl Storz Endoskope, Germany). In patients who
had cyanotic or apnea spells, assessment for laryngomalacia, supraglottic
stenosis, vocal cord paralysis, tracheooseophageal cleft, initially missed
proximal TEF and tracheomalaciawas performed by tracheobronchoscopy
in general anaesthesia with spontaneous breathing. Tracheomalacia was
regarded significant if during expiration the tracheal lumen occluded
50% or more. If ALTE or respiratory problems could not be managed with
maximum treatment of GORD and positive end respiratory pressure
(PEEP) mask producing 5–8 H20cm PEEP, fundoplication combined with
aortopexywas considerednecessary. Recurrent TEFwas excludedwith en-
doscopicmethyleneblue test, air bubble test orwith supine lateral oesoph-
ageal contrast radiograph [6]. Patients with congenital heart disease or
with were re-referred to cardiologist assessment. Most fundoplications
for early postrepair GORD were performed through open abdominal
route as emergent or semiemergent operations preferably by the surgeon
whoperformedor supervised the original repair. BecausepostrepairGORD
symptoms are intermixed with features of stenotic oesophageal anasto-
mosis, tracheomalacia and respiratory problems.
All patients with OA with or without fundoplication underwent a
programmed endoscopic surveillance from one to 15 years of age. Non-
scheduled endoscopies, contrast studies or pH/impedance-monitorings
were performed when deemed necessary, for example, because of re-
curred GORD. In follow-up endoscopy patency of the fundoplication
was assessed from oral direction and by viewing the gastrooesophageal
junction and the fundoplication wrap from retrograde direction by
inverting the gastroscope in air-filled stomach. Signs of failed
fundoplication included loose or absent wrap, wrap retraction into tho-
rax or hiatal and paraesophageal hernias [13]. Esophagitis was graded
histologically as none, mild, moderate or severe. Ofmetaplastic changes
only intestinal metaplasia (columnar epithelium and goblet cells) was
recorded [14,15]. Mild esophagitis, a very common finding in GERD,
was not considered significant. In pH monitoring acidic reflux over
10% of the total measurement time or 5% of total time minus two
hours after meals or reflux periods exceeding five minutes [16] were
considered pathologic. Impedance was recorded synchronously with
the pH/impedance probe, but because impedance in a repaired oesoph-
agus can be expected to be abnormal [17] and no reference values were
available, impedance had no actual effect on the decision to perform
fundoplication.Main outcome measures were survival and degree of oral intake.
Surgical complications were also recorded and assessed. Statistical cal-
culations were made with StatView® 512computer programme (Brain
Power, Calabasas CA, USA). Data are presented as frequencies or me-
dians with interquartile range (IQR). Categorical variables were com-
pared with Fisher's Exact Test, Risk Ratios with Logistic Regression
Analysis. P values b0.05 were considered statistically significant. Data
are quoted as median (interquartile range) unless otherwise indicated.
2. Results
During the study period 1980 to 2016 we treated 290 successive
children with OA; twenty-two were referred from elsewhere. Five in-
fants with Gross C-type OA and trisomy of chromosome 13 (n= 2), ex-
treme prematurity (n=1) diedwithout undergoing definite repair and
23 (type A n=11, B n=4 and C n=5) underwent oesophageal recon-
structionwithout attempt of end-to-end repair. Includedwere 262with
native oesophagus at the time of fundoplication A (n=12), B (n=2), C
(n = 217), D (n = 10), E (n = 19) and F (n = 2). A total of 86 of 262
(33%) underwent fundoplication at the median age of 5.4 (IQR
3.1–16)months. Fundoplications by atresia type and associated anoma-
lies are outlined in Table 1.
2.1. Indications and techniques
Main indications for fundoplication included recalcitrant anastomot-
ic stenosis (RAS) in 41 (48%) (type A n=7, B n=1, C n=29, D n=3, F
n= 1) acute life threatening events (ALTE) in 15 (17%) (type C n= 14,
D n = 1) respiratory symptoms in 16 (19%) (type A n = 2, C n = 14, D
n = 1) persistent oesophagitis in 11 (13%) (type C n = 11) and persis-
tent vomiting in 3 (3%) (A n = 1, B n = 1, C n = 1) patients.
Seventy-nine (92%) patients underwent an open operation (Nissen
n = 49, Boix–Ochoa n = 23, Toupet n = 7) and seven (8%) had a lapa-
roscopic Nissen fundoplication. Median age at open operation was 5.4
(IQR 3–17) months and at laparoscopic operation 8.5 (5.1–49) months
(P = 0.28).
3. Results of fundoplication
3.1. Anastomotic stenosis
Median age of at fundoplicationwas 4.2 (IQR 2.7–6.3)months. Of 41
patients with recurrent anastomotic stenosis 30 (73%) eventually
responded to postfundoplication endoscopic dilatations. Nine patients
(types A n = 2, C n = 5, F n = 1) underwent rethoracotomy, resection
of the stenosed anastomosis and end to end resection and eventually
responded to continued dilatations. In addition, three patients with C-
Table 2
Indication for fundoplication in patients with oesophageal atresia (RAS = recalcitrant












A (n = 10) 7 0 2 0 1
B (n = 2) 1 0 0 0 1
C (n = 68) 29 14 14 11 1
D (n = 4) 3 1 0 0 0
F (n = 1) 1 0 0 0 0
Table 3
Endoscopic follow-up frombirth to latest follow-up endoscopy, all OApatients from1980-


















• no 127 (77%) 54 (69%) 0.16
• mild 33 (20%) 19 (24%) 0.50
• moderate 5 (3%) 5 (6%) 0.30
• severe 0 (0%) 1 (1%) 0.32
• lost to follow-up 39 7 0.02
Metaplasia
• No 156 (94%) 65 (82%) 0.04
• Gastric 8 (5%) 12 (15%) 0.01
• Intestinal 1 (1%) 2 (3%) 0.24
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sophageal reconstruction because of a long stenotic area (from 4 to
5 cm) and associated recurrent fistula in two patients. Reconstructions
included jejunum interposition (n= 1), gastric pull-up (n= 1) and re-
versed gastric tube (n = 1).
3.2. Acute life threatening events (ALTE)
Median age of at fundoplicationwas 2.9 (IQR 2.2–4.6)months. Offif-
teen patients with ALTE 9 (36%) underwent aortopexy for
tracheomalacia. Fundoplication with or without aortopexy controlled
ALTE in 10 (66%). In three children with congenital heart disease
(Fallot's tetralogy) ALTE stopped only after heart surgery. In two pa-
tients who underwent fundoplication with aortopexy for
tracheomalacia ALTE persisted for two and threemonths but eventually
attenuated and ceased.
3.3. Respiratory symptoms
Median age at fundoplicationwas 17 (IQR 11–29)months. Of seven-
teen childrenwho underwent fundoplication for respiratory GER symp-
toms three had undergone a previous aortopexy for tracheomalacia.
Five (29%) children had an associated syndrome (CHARGE n = 2, Di
George n = 1, Down's syndrome (n = 2). In all seventeen patients
fundoplication attenuated respiratory symptoms, but none had total
cessation of respiratory symptoms.
3.4. Persistent oesophagitis
Median age at fundoplication was 110 (IQR45–180) months. Eleven
patients had GORD symptomswith endoscopically verifiedmoderate or
severe mucosal inflammation consistent with reflux oesophagitis. Be-
fore fundoplication all patients were administered proton pump inhib-
itors (1–2 mg/kg once daily) or ranitidine (5–10 mg/kg twice daily)
for several months and the healing surveyed with repeated endoscopic
biopsies. After a median of 115 (IQR 56–165) months of endoscopic
follow-up eight (73%) children had no oesophagitis, two (18%) had
mild oesophagitis, and one (9%) severe oesophagitis. In two with mild
(n=1) and severe (n=1) oesophagitis biopsies showed also columnar
(gastric) metaplasia.
3.5. Vomiting
Median age at fundoplicationwas 15 (IQR 9–26)months. Three chil-
dren underwent fundoplication for persistent copious vomiting that
was detrimental to enteral nutrition. One patient with A-type OA had
a severe dumping syndrome. In all three vomiting was controlled by
fundoplication and enteral nutrition was successfully continued.
3.6. Mortality, preservation of native oesophagus and long term endoscopic
follow-up
Mortality in OA with fundoplication was 6/86 (7%) and in
nonfundoplicated OA 17 /187 (9%) (P = 0.81). Of six children who
died after fundoplication, four died of sequelae of heart surgery; one
of the four had also severe associated tracheomalacia. One patient
with isolated C-type OA with postrepair ALTE underwent
fundoplication with aortopexy for moderate tracheomalacia and repair
of minor laryngeal cleft by otolaryngologist. After fourmonths and after
a six-week remission of ALTE the child, however, succumbed to ALTE
during hisfirst probationary discharge. In addition, one child died of suf-
focation by a food bolus obstruction three months after fundoplication.
Three (3%) of 86 underwent oesophageal reconstruction (see anas-
tomotic stenosis).
Endoscopic follow-up covered 244 (86%) of the 290 patients. Of the
missing 46 patients 20 died before joining the follow-up program and26 patients (OA type E n = 10, type C n = 16) were lost to follow-up.
Patients included in the follow-up underwent a median of 3 (IQR 2–4)
endoscopies during the follow-up. Results from the last endoscopy are
outlined in Table 2. Children who underwent fundoplication had higher
incidence of gastric metaplasia than nonfundoplicated patients. No
cases with dysplasia or cancer were found. (See Table 3.)3.7. Failed fundoplication
Endoscopic follow-up after the first fundoplication was found to be
intact in 59 (69%) of children after a median of 7.8 (IQR 2.0–15) years.
In 27 (31%) children, fundoplication failed after a median of 17 (IQR
8–183) months of follow-up. Failure rate in type A OA was 7/10 (70%),
B 0/2 (0%), C 20/69 (29%), D 0/4(0%) and F 0/1 (0%). Logistic regression
analysis of fundoplication failure showed that long gap OA (type A or
B) was the only statistically significant predisposing factor, RR = 3.8
(95%CI = 1.1–13); P = 0.04.
Of 27 children with failed fundoplication two underwent oesopha-
geal reconstruction because of recalcitrant anastomotic stenosis and re-
current tracheooesophageal fistula. Thirteen (54%) patients (OA type A
n = 4, type C n = 9) underwent redo fundoplication because of recur-
rent significant symptoms of GORD amedian of 17(IQR 5.6–37)months
after the first fundoplication. Indications for redo fundoplication (RAS
n = 2, respiratory symptoms n = 5, vomiting n = 5, dysphagia n =
1) differed from the indications from the original fundoplication (RAS
n = 11, ALTE n = 1, respiratory symptoms n = 1). Among 13 children
with redo fundoplications four (31%) had a new failure and nine remain
with a patent fundoplication.
Among the remaining 12 childrenwith failed fundoplication (type A
OA n = 3, type C n = 9) (original indications RAS n = 6, ALTE n = 4,
respiratory symptoms n = 1, oesophagitis n = 2, vomiting n = 1)
GORD associated symptoms attenuated or were successfully managed
nonoperatively in nine. Seven with failed first or redo fundoplication
remained with significant GORD symptoms. Of these seven, three
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aremanagedwith feeding jejunostomy (n=2) or gastrostomy (n=2).4. Discussion
About 1/3 of our present series of children bornwith OA are coming to
fundoplication.We feel that ourmainfindings are a relatively lowmortal-
ity (7%) caused by OA associated diseases rather by the fundoplication it-
self. Fundoplication aidedmaterially in themanagement of GORD related
symptoms although complete control of symptoms was not achieved.
This is mainly because of the etiology of ALTE and respiratory symptoms
in patients with OA is multifactorial including GORD, tracheomalacia,
heart disease and reactivity of the respiratory tract and the decision to
fundoplication is often based on clinical findings. Management of GORD
with fundoplication had positive effect on the resolution of recurring ste-
nosis of the oesophageal anastomosis by endoscopic dilatation. However,
in approximately one fourth of the patients with anastomotic stenosis
fundoplication did not result in resolution of the stenosis by continued di-
latations, and surgerywas required. Failure rate of fundoplicationwas rel-
atively high, 31%, but compared with contemporary literature not
exceptionally high in patients with OA [18,19]. Lastly endoscopic follow-
up showed that those who have undergone fundoplication, i.e. those
with the severest form of OA associated GORD, have a similar rate of
oesophagitis and intestinal metaplasia as other patients with OA.
The weakness of our study is its retrospective design. Excluding
anastomotic stenosis that can be diagnosed with an endoscope with
reasonable objectivity, detailed assessment or grading of GORD symp-
toms such as heartburn and respiratory symptoms and their attenua-
tion after fundoplication by retrospective review of hospital records is
difficult. We could not show in a statistical analysis how much
fundoplication benefited the management of recalcitrant anastomotic
stenosis, that is, whether lasting anastomotic patency was achieved
with less endoscopic dilatations that would have been the case without
fundoplication, because we had no control group of patients with recal-
citrant anastomotic stenosiswithout fundoplication. Endoscopic follow-
up, while being imposed on the majority of the patients, was not
comparable of themodern diagnostic standards of Barrett's oesophagus.
GORD in those with OA is often persistent and it is known that the in-
cidence of premalignant oesophageal mucosal changes such as Barrett's
esophagus with intestinal metaplasia increases when the patients reach
young adult age [9,10]. In the present series the incidences of oesophagitis
and intestinal metaplasia were relatively low in patients both with and
without fundoplication. Compared with the rest of the series the patients
who underwent fundoplication had higher rate of gastric metaplasia.
While gastric metaplasia may be a result of an oesophageal biopsy taken
too distally in relation to the oesophagogastric junction, an error easily
made in a fundoplicated patient, the presence of gastric metaplasia in the
distal oesophageal mucosa may be a true finding and signal the coexis-
tence of intestinalmetaplasia [20].Whether fundoplication offers any pro-
tection against Barrett's oesophagus cannot be confirmed by our results.
We found that failure of fundoplication was common in patients
with OA, and those with long-gap OA are at the highest risk of failure.GORD could be managed conservatively after the failure of the
fundoplication in less than half of our cohort. We observed that several
patients who as infants underwent fundoplication and had successful
treatment of RAS or ALTE suffered failure of the fundoplication but the
remaining GORD symptoms could be managed conservatively. In the
majority of patients, however, failure of fundoplication resulted in re-
currence of symptoms of GORD, although often in other forms than
RAS or ALTE. After failure of first fundoplication, a trial of conservative
managementmay, however, beworth trying becausewe found a not in-
significant failure rate also in redo fundoplications.
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